Open an account

Chiron Real Estate

XRN · NYSE

$29.98+$0.49 (+1.66%)TodayMarket closed ·
Prev close $29.49

About XRN

Chiron Real Estate, Inc. engages in the acquisition of purpose-built healthcare facilities and the leasing of those properties to healthcare systems and physician groups. The company is headquartered in Bethesda, Maryland and currently employs 30 full-time employees. The company went IPO on 2012-11-02. The firm acquires healthcare facilities leased to physician groups and regional and national healthcare systems. The firm conducts its business through its limited partnership subsidiary, Chiron Real Estate LP (operating partnership). The company owns 92.0% of the outstanding common operating partnership units (OP Units) of its operating partnership, with an aggregate of 8.0% of the operating partnership owned by holders of long-term incentive plan units (LTIP Units) and third-party limited partners who contributed properties or services to the Operating Partnership in exchange for OP Units. Its portfolio includes medical office buildings (MOBs), inpatient rehab. facility (IRF), surgical hospitals and others. Its portfolio is located in various areas, including Texas, Florida, Ohio, Arizona, Pennsylvania, Illinois, and Others.

Employees
30
Headquarters
Bethesda, Maryland
Listed
Nov 2, 2012
Sector
Real Estate
Industry
Health Care REITs
Website
chironre.com

XRN key statistics

Market cap
472.09M
Price-earnings ratio
7.99
Dividend yield
12.49%
Average volume
132.54K
Volume
261.35K
Open price
$29.65
High today
$30.17
Low today
$29.37
52 Week high
$38.65
52 Week low
$29.05

Chiron Real Estate (XRN) at a glance

As of Oct 20, 2026, Chiron Real Estate (XRN) shares are priced at $29.98, giving the company a market cap of 472.09M, a price-to-earnings ratio of 7.99 and a dividend yield of 12.49%.

Today the stock has traded between $29.37 and $30.17. The current price is 2.1% above the day's low and 0.6% below its high.

Volume so far is 261.35K shares, above the average of 132.54K shares a day.

Over the past year Chiron Real Estate has ranged from $29.05 to $38.65, and now sits 10% of the way up that range.

Chiron Real Estate met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported $4.78 per share against an estimate of -$0.2374.

The average analyst price target is $42.50, 41.8% above the current price, from 5 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

40%of 5 analyst ratings say Buy
  • Buy40.0%
  • Hold60.0%
  • Sell0.0%
Price target · 10 analystsAvg $42.50
Low
$37.37
Now
$29.98
High
$48.30

XRN earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 569.6% on average.

  1. Q3 FY24: reported $0.15 per share against an estimate of $0.1178
  2. Q4 FY24: reported $0.25 per share against an estimate of $0.00
  3. Q1 FY25: reported $0.15 per share against an estimate of $0.0631
  4. Q2 FY25: reported -$0.05 per share against an estimate of $0.1515
  5. Q3 FY25: reported $0.02 per share against an estimate of $0.0471
  6. Q4 FY25: reported -$0.55 per share against an estimate of $0.0657
  7. Q1 FY26: reported -$0.06 per share against an estimate of $0.0101
  8. Q2 FY26: reported $4.78 per share against an estimate of -$0.2374

XRN news

  • Press releaseBusiness Wire

    Chiron Real Estate Inc. Announces Dates for 2026 Third Quarter Earnings Release and Webcast

  • Press releaseBusiness Wire

    Chiron Real Estate Appoints Charles P. Fitzgerald Chairman of the Board

  • Press releaseBusiness Wire

    Chiron Real Estate Inc. Announces Employee Inducement Awards Under NYSE Rule 303A.08

  • Press releaseBusiness Wire

    Chiron Real Estate Inc. Announces the Declaration of its October, November and December 2026 Common Dividends and Third Quarter Series A and Series B Preferred Dividends

  • Press releaseBusiness Wire

    Chiron Real Estate Inc. Announces Second Quarter 2026 Financial Results

  • Press releaseBusiness Wire

    Chiron Real Estate Inc. Announces Employee Inducement Awards Under NYSE Rule 303A.08

  • Press releaseBusiness Wire

    Chiron Real Estate Inc. Appoints Matthew Whitlock as Chief Investment Officer

  • Press releaseBusiness Wire

    Chiron Real Estate Inc. Announces Dates for 2026 Second Quarter Earnings Release and Webcast

Similar companies

Companies in the same industry as Chiron Real Estate

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.